Keros Therapeutics (KROS) Q3 2025 Earnings

Aug 6Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.41
0.27
1.94
3.62

Details

Expected EPS
-1.109809
Actual EPS
-0.76
Surprise EPS
0.35
Surprise Percent
+31.52%

Description

⁨Keros Therapeutics⁩ (⁦KROS⁩) has reported earnings of ⁦-0.76⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts